Weill Medical College Of Cornell University
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1865-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://weill.cornell.edu
Clinical Trials
848
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (659 trials with phase data)• Click on a phase to view related trials
Technology-Based Intervention Usability and Pilot Testing
- Conditions
- DementiaElder AbuseElder Neglect
- First Posted Date
- 2025-08-28
- Last Posted Date
- 2025-08-28
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 40
- Registration Number
- NCT07146581
- Locations
- 🇺🇸
Weill Cornell Medicine, New York, New York, United States
STICH3C Cardiac Magnetic Resonance Observational Study
- Conditions
- Ischemic Left Ventricle Systolic DysfunctionMultivessel Coronary Artery Disease
- First Posted Date
- 2025-08-21
- Last Posted Date
- 2025-08-21
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 200
- Registration Number
- NCT07133984
- Locations
- 🇺🇸
NewYork-Presbyterian Brooklyn Methodist Hospital, Brooklyn, New York, United States
🇺🇸New York Presbyterian - Queens, Flushing, New York, United States
🇺🇸Weill Cornell Medicine/NewYork Presbyterian Hospital, New York, New York, United States
Use of Gocovri to Improve Disability Due to Radiation Encephalopathy
- Conditions
- Radiation Encephalopathy
- Interventions
- Drug: Gocovri (extended-release amantidine)
- First Posted Date
- 2025-08-15
- Last Posted Date
- 2025-08-15
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 24
- Registration Number
- NCT07125222
- Locations
- 🇺🇸
Weill Cornell Medicine, New York, New York, United States
Patient-engaged Development and Testing of Educational Content on Side Effects of Statins
- Conditions
- Dyslipidemia
- First Posted Date
- 2025-07-30
- Last Posted Date
- 2025-07-30
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 30
- Registration Number
- NCT07094412
- Locations
- 🇺🇸
Weill Cornell Medicine, New York City, New York, United States
Testing for Safety and Immune Effects of PDS0101, an Anti-HPV Therapy, Among People Living With HIV
- Conditions
- HPV Associated CancersHIV (Human Immunodeficiency Virus)Anal CancerCervical CancerHPV 16 Infection
- Interventions
- First Posted Date
- 2025-07-29
- Last Posted Date
- 2025-07-31
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 27
- Registration Number
- NCT07090174
- Locations
- 🇺🇸
Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, New York, United States
🇺🇸Weill Cornell Medical College, New York, New York, United States
🇵🇷University of Puerto Rico, San Juan, Puerto Rico
- Prev
- 1
- 2
- 3
- 4
- 5
- 169
- Next